European regulatory approval paves the way for Dermalyser’s clinical rollout, enhancing early skin cancer diagnosis through advanced AI technology.
AI-driven system targets real-time, lab-quality disease detection at the point of care
Natus Medical yesterday announced that it launched BrainWatch, a point-of-care EEG solution driven by AI.
Researchers from the University of Tokyo have found a way to observe clotting activity in blood as it happens—without needing invasive procedures. Using a new type of microscope and artificial intelligence (AI), their study shows how platelet clumping can be tracked in patients with coronary artery disease (CAD), opening the door to safer, more personalized treatment.
GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.
Milestone Approvals Enable European and UK Market Access for AI-Based Cardiac Arrest Prediction Tool
New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage
Two meters of DNA is crammed into the nucleus of every human cell. Bin Zhang wants to know how gene expression works in this minuscule space.
This historic acquisition reduces barriers that prevent people from taking control of their lifelong health. Full Body MRI scan now takes just 22 minutes instead of 60 minutes, costs $499 instead of over $1,500
Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out individual cells. The technique provides imaging resolution that rivals the most advanced devices available and is cheaper, faster, and doesn’t require specialized equipment or expertise. The strategy has implications for early detection of disease and for the monitoring of treatment response by making what was once invisible now visible.